Engineering strategies for generating hypoimmunogenic cells with high clinical and commercial value.

Engineering strategies for generating hypoimmunogenic cells with high clinical and commercial value. Regen Med. 2019 Oct 30;: Authors: Malik NN, Jenkins AM, Mellon J, Bailey G PMID: 31663432 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31663432?dopt=Abstract

Source: Regenerative Medicine - October 29, 2019 Category: Genetics & Stem Cells Authors: Malik NN, Jenkins AM, Mellon J, Bailey G Tags: Regen Med Source Type: research

More News: Genetics